Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00896948 · ClinicalTrials.gov registry record
Study of Proteins in Head and Neck Cancer Cells
A clinical trial of Head and Neck Cancer, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 3
- Study locations
NCT00896948: Completed study of Head and Neck Cancer, sponsored by Vanderbilt University Medical Center.
NCT00896948 is a study of Head and Neck Cancer that has completed, run by Vanderbilt University Medical Center. The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00896948, a study of Head and Neck Cancer, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 3
- Study locations
Study Summary
RATIONALE: Studying proteins in head and neck cancer cells in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at proteins in head and neck cancer cells.
Conditions Studied
Interventions
- GENETIC gene expression analysis
- GENETIC protein expression analysis
- OTHER flow cytometry
- GENETIC TdT-mediated dUTP nick end labeling assay
- GENETIC Southern blotting
Study Locations (3)
Tennessee
- Vanderbilt-Ingram Cancer Center - Cool Springs - Nashville
- Vanderbilt-Ingram Cancer Center at Franklin - Nashville
- Vanderbilt-Ingram Cancer Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Start Date | 2005-05 |
What the finished NCT00896948 record still lists
NCT00896948 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 5 interventions - of which gene expression analysis is the first listed.
NCT00896948 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00896948 about?
NCT00896948 is a clinical study titled "Study of Proteins in Head and Neck Cancer Cells". RATIONALE: Studying proteins in head and neck cancer cells in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at proteins in head and neck cancer cells.
What is the current status of trial NCT00896948?
This trial is currently completed. The study started on 2005-05.
What conditions does trial NCT00896948 study?
This clinical trial studies the following conditions: Head and Neck Cancer.
What interventions are being tested in trial NCT00896948?
The interventions under investigation include: gene expression analysis (GENETIC), protein expression analysis (GENETIC), flow cytometry (OTHER), TdT-mediated dUTP nick end labeling assay (GENETIC), Southern blotting (GENETIC).
Who is sponsoring clinical trial NCT00896948?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00896948 being conducted?
This trial has 3 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
3D Specimen Maps for RT Planning
RECRUITING
-
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
RECRUITING · Phase 1
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck
RECRUITING · NA
-
RAPA-201 Therapy of Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia